Cargando…

DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis

OBJECTIVE: Guidelines do not specify how cutoffs for high disease activity differ between the Disease Activity Score 28‐joint count indices DAS28–erythrocyte sedimentation rate (ESR) and DAS28–C‐reactive protein (CRP). Studies that compare DAS28‐CRP and DAS28‐ESR depend on data from clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenmyer, Jacob R., Stacy, John M., Sahmoun, Abe E., Beal, James R., Diri, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504477/
https://www.ncbi.nlm.nih.gov/pubmed/32862564
http://dx.doi.org/10.1002/acr2.11171
_version_ 1783584634048610304
author Greenmyer, Jacob R.
Stacy, John M.
Sahmoun, Abe E.
Beal, James R.
Diri, Erdal
author_facet Greenmyer, Jacob R.
Stacy, John M.
Sahmoun, Abe E.
Beal, James R.
Diri, Erdal
author_sort Greenmyer, Jacob R.
collection PubMed
description OBJECTIVE: Guidelines do not specify how cutoffs for high disease activity differ between the Disease Activity Score 28‐joint count indices DAS28–erythrocyte sedimentation rate (ESR) and DAS28–C‐reactive protein (CRP). Studies that compare DAS28‐CRP and DAS28‐ESR depend on data from clinical trials, registries, or practices with multiple providers. Existing studies use data from patients who received immunosuppressive therapy. This study compared the DAS28‐ESR and DAS28‐CRP values from immunosuppressive treatment–naïve patients in a single physician practice. METHODS: A retrospective electronic medical chart review was conducted for new diagnoses of rheumatoid arthritis (RA; International Classification of Diseases [ICD]‐9 714), based on the American College of Rheumatology/European League against Rheumatology 2010 RA classification criteria. The number of patients with high disease activity (>5.1) was compared using ESR and CRP data to calculate the proportion of discordance. A receiver operator curve and Youden index was used to calculate the DAS28‐CRP high disease activity cutoff estimation that corresponds with DAS28‐ESR of more than 5.1. RESULTS: There were 171 patients included in this study. The baseline mean DAS28‐ESR was higher than the baseline mean DAS‐28 CRP: 5.1 ± 1.2 versus 4.1 ± 1.0 (P < 0.001); 48.5% of patients met criteria for high disease activity (score >5.1) compared with only 14.6% when measured by DAS28‐CRP. Discordance was 33.9%. κ coefficient was only .307. Receiver operator curve and Youden index analysis suggested that the cutoff point for high disease activity of DAS28‐CRP greater than 4.1, which corresponds to DAS28‐ESR greater than 5.1. Similarly, DAS28‐ESR posttreatment scores were significantly higher than DAS28‐CRP. When measured by DAS28‐ESR, patients in remission had higher scores as measured by DAS28‐ESR (1.81) than DAS28‐CRP (1.45). CONCLUSION: There is a difference between DAS28‐ESR and DAS28‐CRP, even when calculated for immunosuppressive treatment–naïve patients. DAS28‐CRP is significantly lower than DAS28‐ESR.
format Online
Article
Text
id pubmed-7504477
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75044772020-09-28 DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis Greenmyer, Jacob R. Stacy, John M. Sahmoun, Abe E. Beal, James R. Diri, Erdal ACR Open Rheumatol Brief Report OBJECTIVE: Guidelines do not specify how cutoffs for high disease activity differ between the Disease Activity Score 28‐joint count indices DAS28–erythrocyte sedimentation rate (ESR) and DAS28–C‐reactive protein (CRP). Studies that compare DAS28‐CRP and DAS28‐ESR depend on data from clinical trials, registries, or practices with multiple providers. Existing studies use data from patients who received immunosuppressive therapy. This study compared the DAS28‐ESR and DAS28‐CRP values from immunosuppressive treatment–naïve patients in a single physician practice. METHODS: A retrospective electronic medical chart review was conducted for new diagnoses of rheumatoid arthritis (RA; International Classification of Diseases [ICD]‐9 714), based on the American College of Rheumatology/European League against Rheumatology 2010 RA classification criteria. The number of patients with high disease activity (>5.1) was compared using ESR and CRP data to calculate the proportion of discordance. A receiver operator curve and Youden index was used to calculate the DAS28‐CRP high disease activity cutoff estimation that corresponds with DAS28‐ESR of more than 5.1. RESULTS: There were 171 patients included in this study. The baseline mean DAS28‐ESR was higher than the baseline mean DAS‐28 CRP: 5.1 ± 1.2 versus 4.1 ± 1.0 (P < 0.001); 48.5% of patients met criteria for high disease activity (score >5.1) compared with only 14.6% when measured by DAS28‐CRP. Discordance was 33.9%. κ coefficient was only .307. Receiver operator curve and Youden index analysis suggested that the cutoff point for high disease activity of DAS28‐CRP greater than 4.1, which corresponds to DAS28‐ESR greater than 5.1. Similarly, DAS28‐ESR posttreatment scores were significantly higher than DAS28‐CRP. When measured by DAS28‐ESR, patients in remission had higher scores as measured by DAS28‐ESR (1.81) than DAS28‐CRP (1.45). CONCLUSION: There is a difference between DAS28‐ESR and DAS28‐CRP, even when calculated for immunosuppressive treatment–naïve patients. DAS28‐CRP is significantly lower than DAS28‐ESR. John Wiley and Sons Inc. 2020-08-29 /pmc/articles/PMC7504477/ /pubmed/32862564 http://dx.doi.org/10.1002/acr2.11171 Text en © 2020 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Brief Report
Greenmyer, Jacob R.
Stacy, John M.
Sahmoun, Abe E.
Beal, James R.
Diri, Erdal
DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
title DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
title_full DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
title_fullStr DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
title_full_unstemmed DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
title_short DAS28‐CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28‐ESR in Rheumatoid Arthritis
title_sort das28‐crp cutoffs for high disease activity and remission are lower than das28‐esr in rheumatoid arthritis
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504477/
https://www.ncbi.nlm.nih.gov/pubmed/32862564
http://dx.doi.org/10.1002/acr2.11171
work_keys_str_mv AT greenmyerjacobr das28crpcutoffsforhighdiseaseactivityandremissionarelowerthandas28esrinrheumatoidarthritis
AT stacyjohnm das28crpcutoffsforhighdiseaseactivityandremissionarelowerthandas28esrinrheumatoidarthritis
AT sahmounabee das28crpcutoffsforhighdiseaseactivityandremissionarelowerthandas28esrinrheumatoidarthritis
AT bealjamesr das28crpcutoffsforhighdiseaseactivityandremissionarelowerthandas28esrinrheumatoidarthritis
AT dirierdal das28crpcutoffsforhighdiseaseactivityandremissionarelowerthandas28esrinrheumatoidarthritis